Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Foresite Capital Opportunity Management V LLC
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-12-29
Purchase
2023-01-03
4:24 pm
Theseus Pharmaceuticals Inc.THRXForesite Capital Management V LLC
Foresite Capital Fund V L.P.
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
Tananbaum James B.
10% Owner
500,000$5$2,500,0001,209,275
(Indirect)
View
2021-12-22
Purchase
2021-12-23
4:52 pm
PARDES BIOSCIENCES IncPRDSTananbaum James B.
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
Director
10% Owner
325,000$10$3,250,000325,000
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-06-09
Ownership
2022-06-13
5:15 pm
N/A
N/A
Theseus Pharmaceuticals Inc.THRXForesite Capital Management V LLC
Foresite Capital Fund V L.P.
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
Tananbaum James B.
10% Owner
0$04,294,621
(Indirect)
View
2021-12-23(A)
Option Award
2022-06-10
4:17 pm
N/A
2031-12-22
PARDES BIOSCIENCES IncPRDSTananbaum James B.
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
Director
10% Owner
75,000$075,000
(Direct)
View
2021-12-23(A)
Conversion
2021-12-30
4:30 pm
N/A
N/A
PARDES BIOSCIENCES IncPRDSTananbaum James B.
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
Director
10% Owner
4,941,250$04,941,250
(Indirect)
View
2021-12-23
Option Award
2021-12-28
4:30 pm
N/A
N/A
PARDES BIOSCIENCES IncPRDSTananbaum James B.
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
Director
10% Owner
1,000,000$108,761,572
(Indirect)
View
2021-12-23
Conversion
2021-12-28
4:30 pm
N/A
N/A
PARDES BIOSCIENCES IncPRDSTananbaum James B.
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
Director
10% Owner
4,873,750$08,761,572
(Indirect)
View
2021-12-23
Option Award
2021-12-28
4:30 pm
N/A
2031-12-22
PARDES BIOSCIENCES IncPRDSTananbaum James B.
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
Director
10% Owner
7,834,072$08,761,572
(Direct)
View
2021-03-23
Ownership
2021-03-25
4:08 pm
N/A
N/A
FS Development Corp. IIFSIIForesite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
10% Owner
0$05,633,750
(Indirect)
View
2021-02-05
Option Award
2021-02-09
3:04 pm
N/A
N/A
Gemini Therapeutics Inc.GMTXFS Development Holdings LLC
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
Director by Deputization
10% Owner
1,500,000$103,370,250
(Direct)
View
2021-02-05
Conversion
2021-02-09
3:04 pm
N/A
N/A
Gemini Therapeutics Inc.GMTXFS Development Holdings LLC
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
Director by Deputization
10% Owner
2,928,750$03,370,250
(Direct)
View
2020-12-07
Conversion
2020-12-09
1:35 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Management V LLC
Foresite Capital Fund V L.P.
Foresite Capital Opportunity Management V LLC
Foresite Capital Opportunity Fund V L.P.
10% Owner
19,675,448$0291,667
(Indirect)
View
2020-12-03
Option Award
2020-12-04
8:57 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Management V LLC
Foresite Capital Fund V L.P.
Foresite Capital Opportunity Management V LLC
Foresite Capital Opportunity Fund V L.P.
10% Owner
1,000,000$20125,000
(Indirect)
View
2020-12-02
Ownership
2020-12-03
06:03 am
N/A
N/A
Kinnate Biopharma Inc.KNTEForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Management V LLC
Foresite Capital Fund V L.P.
Foresite Capital Opportunity Management V LLC
Foresite Capital Opportunity Fund V L.P.
10% Owner
0$09,838,311
(Indirect)
View
2020-10-19
Ownership
2020-10-27
4:13 pm
N/A
N/A
FS Development Corp.FSDCForesite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
10% Owner
0$03,370,250
(Indirect)
View
(A) Indicate amendment filing.